HEALTH● ELEVATED2h ago · Oct 24, 2026, 6:00 AM
Roche Reports Positive Phase III Data For Investigational IgAN Therapy Sefaxersen
finanzen.ch · Switzerland · global
Roche has reported positive Phase III trial data for Sefaxersen, an investigational therapy for IgAN. This development could lead to a new treatment option for the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapSwitzerland and nearby eventsMore from SwitzerlandLatest stories and threat level
More from Switzerland
More in Health
HEALTH31m agoWinter time or summer time? What the science says about the best option for healthEuroNews [en]HEALTH51m agoEbola vaccine trial begins in DR CongoVanguard NigeriaHEALTH1h agoClocks turn back on November 1: how to maintain your biological clock and sleep well with the time changeClarínHEALTH1h agoPsychology says that parents who have good intentions but still deeply hurt their children often say 6 phrases in informal conversationsClarín